| WKN: | A1J2YC |
| ISIN: | AU000000ALQ6 |
| Land: | Australien |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Biotechnologie |
Weshalb die ALS-Aktie
ein A-Rating hat,
erfahren Sie im Performance-Check
vom 30. November 2025 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2016 | 2,57 | 4,07 | 58,37% |
| 2 | 2021 | 5,95 | 8,40 | 41,18% |
| 3 | 2019 | 4,14 | 5,75 | 38,89% |
| 4 | 2025 | 8,95 | 12,30 | 37,43% |
| 5 | 2024 | 7,80 | 8,95 | 14,74% |
| 6 | 2017 | 4,07 | 4,49 | 10,32% |
| 7 | 2020 | 5,75 | 5,95 | 3,48% |
| 8 | 2023 | 7,60 | 7,80 | 2,63% |
| 9 | 2018 | 4,49 | 4,14 | -7,80% |
| 10 | 2022 | 8,40 | 7,60 | -9,52% |
| 11 | 2015 | 3,35 | 2,57 | -23,28% |
| 12 | 2013 | 7,86 | 5,31 | -32,44% |
| 13 | 2014 | 5,31 | 3,35 | -36,91% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2014 | 5,31 | 3,35 | -36,91% |
| 2 | 2013 | 7,86 | 5,31 | -32,44% |
| 3 | 2015 | 3,35 | 2,57 | -23,28% |
| 4 | 2022 | 8,40 | 7,60 | -9,52% |
| 5 | 2018 | 4,49 | 4,14 | -7,80% |
| 6 | 2023 | 7,60 | 7,80 | 2,63% |
| 7 | 2020 | 5,75 | 5,95 | 3,48% |
| 8 | 2017 | 4,07 | 4,49 | 10,32% |
| 9 | 2024 | 7,80 | 8,95 | 14,74% |
| 10 | 2025 | 8,95 | 12,30 | 37,43% |
| 11 | 2019 | 4,14 | 5,75 | 38,89% |
| 12 | 2021 | 5,95 | 8,40 | 41,18% |
| 13 | 2016 | 2,57 | 4,07 | 58,37% |